Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Vincenti

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Potential of daclizumab in solid organ transplantationF Vincenti
Transplantation Proceedings|June 19, 2001
Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimenF Vincenti
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|May 30, 2003
New monoclonal antibodies in renal transplantationF Vincenti
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 17, 2012
Beyond belatacept: praise and progress for the FDAF Vincenti
Revue D'Epidemiologie Et De Sante Publique|January 1, 1984
[Elements of descriptive epidemiology on human brucellosis in North Corsica (France) (from 1976 to 1981)]F Vincenti
Transplantation Proceedings|March 27, 2001
The role of newer monoclonal antibodies in renal transplantationF Vincenti
Transplantation Proceedings|September 29, 1999
Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantationF Vincenti
Transplantation Proceedings|March 27, 2001
Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trialF Vincenti
Transplantation Proceedings|December 26, 2001
Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimensF Vincenti
Developments in Biological Standardization|January 1, 1984
[Epidemiological elements of human brucellosis in Upper Corsica]F Vincenti
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Potential of daclizumab in solid organ transplantationF Vincenti
Transplantation Proceedings|June 19, 2001
Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimenF Vincenti
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|May 30, 2003
New monoclonal antibodies in renal transplantationF Vincenti
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 17, 2012
Beyond belatacept: praise and progress for the FDAF Vincenti
Revue D'Epidemiologie Et De Sante Publique|January 1, 1984
[Elements of descriptive epidemiology on human brucellosis in North Corsica (France) (from 1976 to 1981)]F Vincenti
Transplantation Proceedings|March 27, 2001
The role of newer monoclonal antibodies in renal transplantationF Vincenti
Transplantation Proceedings|September 29, 1999
Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantationF Vincenti
Transplantation Proceedings|March 27, 2001
Tacrolimus (FK 506) in kidney transplantation: five-year survival results of the U.S. multicenter, randomized, comparative trialF Vincenti
Transplantation Proceedings|December 26, 2001
Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimensF Vincenti
Developments in Biological Standardization|January 1, 1984
[Epidemiological elements of human brucellosis in Upper Corsica]F Vincenti
Pageof 19